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Abstract 
ECF t F 0 has been purified from three mutants in which a Cys has been incorporated by site-directed mutagenesis n the • subunit: 
these mutants are • S 10C, • H38C and • S 108C, respectively. ECF 1F 0 from the mutant • S10C had a 2-fold higher activity than wild-type 
enzyme, due to altered association of the e subunit with the rest of the complex, and yet showed normal proton pumping function. The 
other two mutants had ATPase activities imilar to wild-type enzyme. The introduced Cys was exposed for reaction with maleimides in 
• S10C and eSI08C. In •H38C, the introduced Cys reacted readily with N-ethylmaleimide in isolated ECF I, but was unavailable for 
reaction with this or other maleimides in ECF~F o. When this Cys at position 38 in the • subunit was reacted with various maleimides in 
isolated ECF t and then the ECF~ bound back to F 0, the interaction between the two parts was perturbed. While ECF] F o reconstituted with 
unmodified ECF I functioned normally, enzyme with maleimide-reacted Cys-38 showed much reduced proton pumping, had only around 
50% of the DCCD inhibition of unmodified or wild-type enzyme, and had a much higher LDAO activation (as much as 8.3-fold, c.f. 
4-fold for wild type). Nucleotide-dependent conformational changes have been observed previously, in studies of ECF] from the mutants 
• S10C and •S 108C. Identical nucleotide-dependent structural changes were observed in cross-linking experiments with tetrafluoropheny- 
lazide maleimides when the intact ECF t F o from these mutants was examined. Taken together, the Cys reactivity data and cross-linking 
results provide the orientation of the • subunit in the enzyme complex. 
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1. Introduction 
The H + ATPase of Escherichia coli (ECF1F 0) cat- 
alyzes both ATP synthesis coupled to an electron chemical 
gradient and ATP hydrolysis-driven proton translocation. 
Abbreviations: MBB, maleimidobutyrylbiocytin; CM, 7-diethyl- 
amino-3-(4'-maleimidylphenyl)-4-methylcoumarin; RM, tetramethylrho- 
damine-5-(and -6)-maleimide; ACMA, 9-amino-6-chloro-2-methoxyacri- 
dine; DCCD, dicyclohexylcarbodiimide; T s, N-tris(hydroxymethyl)- 
methyl-2-aminoethanesulfonic ac d; Hepes, 4-(2-hydroxyethyl)-l- 
piperazineethane sulfonic acid; Mops, 3-(N-morpholino)propanesulfonic 
acid; NaDodSO 4, sodium dodecyl sulfate; LDAO, N,N-dimethyldode- 
cylamine N-oxide; DTE, dithioerythritol; DTT, dithiothreitol; NEM, N- 
ethylmaleimide; TFPAM, tetrafluorophenylazide maleimide; AMP-PNP, 
adenyl-5'-yl-fl,y-imidodiphosphate. 
* Corresponding author. Fax: + 1 503 3464854. 
0005-2728/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSDI 0005-2728(95)00040-2  
The enzyme is made up of two parts: an F l part composed 
of five different subunits, a, /3, y, 6 and e, in the molar 
ratio 3:3:1:1:1, and an F 0 sector containing subunits, a, b 
and c in the ratio 1:2:10-12 [1,2]. The F~ part contains a 
total of six nucleotide binding sites, three catalytic sites 
located mainly on /3 subunits, and three so-called non- 
catalytic sites located mainly on a subunits. The proton 
channel is located in the F 0 sector and is constituted by the 
c subunits and possibly the a subunit [2,3]. 
Low resolution cryoelectronmicroscopy studies show 
the F~ part oseparated from the F 0 by a narrow stalk of 
around 45 A in length [4,5]. This stalk region appears to 
include parts of the y, 6, and e subunits of the F] part and 
the b subunits of the F o part [6,7]. It is now generally 
accepted that events in the catalytic sites of the F 1 part are 
coupled to proton translocation i the F 0 part via long-dis- 
tance conformational changes transmitted through the stalk 
region [2,8]. We are studying structure-function relation- 
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ships by introducing Cys residues into the stalk-forming 
subunits by site-directed mutagenesis. These sites can then 
be used for accessibility studies using maleimides and, if 
exposed, for attachment of cross-linkers, gold maleimides 
[9] and fluorophores [10] as reporters of the structural 
changes occurring. 
We have previously described two mutants in which a 
Cys has been engineered genetically into the E subunit, 
ES10C and ES108C respectively [11]. Both Cys residues 
were reactive to NEM. The Cys at position 10 was found 
to be close to the y subunit by cross-linking with the 
TFPAM series of cross-linkers, while the Cys at position 
108 was close to an a subunit [11]. The C-terminal region 
of ~ around S108 is also close to the /3 subunit based on 
EDC cross-linking of ECF l [ 12,13]. A third Cys-containing 
mutant of the e subunit (EH38C) has been described 
recently by Skakoon and Dunn [14]. Cross-linking studies 
showed the Cys at 38 to be close to the y subunit. 
In the present study, we have examined the NEM 
reactivity of the Cys residues at positions 10, 38 and 108 
of the e subunit in the intact ATP synthase, i.e., ECF~F 0. 
Both Cys-10 and Cys-108 were found to react readily with 
this, and other maleimides, in ECF~F 0. However, the Cys 
at position 38 was not modified by NEM, or other 
maleimides. This observation was followed up by reconsti- 
tution studies in which ECF~ from the mutant eH38C was 
modified by NEM or other maleimides and then rebound 
to F 0. Functional studies of the reconstituted ECF~F 0 indi- 
cate the importance of the region of E around residue 38 
for coupling of ATP hydrolysis to proton translocation by 
the complex. 
2. Experimental procedures 
Bacterial strains, plasmids. The E. coli strains used in 
this study were XL1-Blue from Stratagene for cloning, 
ANI460 [15] for isolation of the wild-type ATP-synthase 
and the unc- strain AN888 as the host for the plasmids 
containing the uric operon with E subunit mutations. The 
plasmids pRA101 (ES10C) and pRA102 (cSI08C) were 
described in Aggeler et al. [11]. 
An unc operon containing plasmid with the eH38C 
mutation was constructed by inserting the AatII/PstI 
fragment of pES4 [14], a generous gift of Dr. Stanley D. 
Dunn (University of Western Ontario), into pBluescript 
containing the 2.8 kb NdeI/EagI fragment followed by 
one containing the 6.1 kb NdeI/XhoI fragment, and fi- 
nally the 5.8 kb NsiI/XhoI fragment into pRA100, as 
described in Aggeler et al. [11] to obtain pRA122. Stan- 
dard subcloning procedures were carried out as described 
in Maniatis et al. [16] and Davis et al. [17]. 
Labeling and Cross-linking of E. coli F 1 ATPase and 
FIFo ATP-synthase - ECFI-ATPase from the eH38C mu- 
tant was modified with TFPAM-6 in 50 mM Mops (pH 
7.0), 0.5 mM EDTA and 10% glycerol followed by re- 
moval of excessive label and photo cross-linking as de- 
scribed in Aggeler et al. [11]. 
ECF~F 0 was reconstituted in egg-lecithin vesicles by 
dialysis as described before [18]. After centrifugation at 
50000 rpm at 4 ° C for 1 h in a Beckman Ti60 rotor, the 
liposomes were resuspended in 50 mM Mops (pH 7.0), 5 
mM MgC12, 20 /xM DTT and 10% glycerol. At a concen- 
tration of 0.5 to 1.0 mg/ml of enzyme, 200/xM TFPAM-6 
was added. After incubation at room temperature for 2 h, 
excess label was removed by two consecutive spins for 40 
min at 70000 rpm in a Beckman TLA100.2 rotor. Photoly- 
sis was carried out for 3 h at room temperature under 
constant stirring with a 6 W 366 nm UV lamp (UVP, 
Model UVL-56, Blak-Ray lamp) at a distance of 2.5 cm. 
[J4C]NEM modification of ECF1F 0 was carried out by 
reacting the enzyme for 1 h with 300 /zM [14C]NEM, 
followed by the addition of 5 mM cysteine for 15 min. 
Samples were electrophoresed on NaDodSOa-polyacryl- 
amide gels, and radioactivity in the subunits was quantified 
as described in Aggeler et al. [18]. 
Rebinding of ECF 1 to ECF o. ATPase and ATP-synthase 
were isolated as described by Gogol et al. [19] and Aggeler 
et al. [18], respectively. ECF 0 containing vesicles were 
obtained by subjecting the ECF~F 0 vesicles, either lipo- 
somes described above or inverted inner membranes, to 
low salt conditions according to LiStscher et al. [20], or by 
the extraction procedure with 1 M KSCN as described in 
Perlin et al. [21] and resuspended in 50 mM Tris-HC1 (pH 
7.5), 5 mM MgSO 4, 1 mM DTE and 10% glycerol. Free 
ECF~ of the various mutants, with or without prior modifi- 
cation with 200 ~M maleimide for 1 h at room tempera- 
ture followed by addition of 2 mM cysteine, was rebound 
to stoichiometric amounts of ECF 0 in the presence of 5 
mM ATP by incubation for 8 h at room temperature. The 
liposomes were pelleted twice by centrifugation for 40 min 
at 70000 rpm in a Beckman TLAI00.2 rotor to remove 
unbound F~ ATPase. 
Other Methods. Protein concentrations were determined 
with the BCA protein assay from Pierce Chemical Co. 
after addition of 1% NaDodSO 4 to the samples containing 
egg-lecithin vesicles. The cross-link products were ana- 
lyzed after electrophoresis on NaDodSO 4 containing 10- 
18% polyacrylamide gels [22], followed by blotting onto 
nitrocellulose membranes with monoclonal antibodies [23]. 
The effect of DCCD on the ATPase activity was assayed 
after incubation of ECF~ F 0 with 20 /zM DCCD for 2 h at 
room temperature with a regenerating system [20] in the 
absence and presence of 0.5% LDAO. The quenching of 
ACMA fluorescence was measured on inner membranes 
with an SLM 8000 fluorometer at 480 nm with an excita- 
tion wavelength of 410 nm essentially according to 
L~Stscher et al. [20]. To a suspension of membranes at a 
protein concentration of 0.2 mg/ml in 10 mM Hepes (pH 
7.5), 100 mM KC1 and 5 mM MgC! 2 were added sequen- 
tially 3.6/xM valinomycin, 1 /xM ACMA, 0.5 mM NADH, 
2 mM KCN, 2 mM ATP and 3.6 /xM nigericin. 
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3. Results 
Mutants in which a Cys residue has been introduced 
into the E subunit are eS10C, eS I08C [11] and •H38C 
[14]. For the studies presented here, the •H38C mutation 
was incorporated into the unc operon as described in the 
Experimental procedures ection and ECFj and ECF~F 0 
prepared from this and the other mutants listed above. 
ATPase activities of ECF~F 0 for the mutants eH38C 
and eS 108C were similar to that of wild-type enzyme, i.e., 
in the range 15-25 /~mol ATP hydrolyzed per min per mg 
protein, the variability depending mostly on the purity of 
different preparations. In contrast, ECF~F 0 isolated from 
the mutant e S10C, reproducibly gave an ATPase activity 
of 40-43 /zmol ATP hydrolyzed per min per mg protein. 
This value is close to that obtained by trypsin treatment of 
wild-type ECFjF 0 [23] and higher than the activity of ECF~ 
isolated from the mutant eS10C, i.e., 30-32 /xmol ATP 
per min per mg [11]. 
3.1. Characterization o f  the •H38C mutant 
The ATPase activity of ECF~ isolated from the mutant 
• H38C of 18 ~mol  ATP hydrolyzed per rain per mg F~ 
was increased 8-fold by addition of 0.5% LDAO, indicat- 
ing that the mutant • subunit binds and efficiently inhibits 
ATPase activity, as reported by Skakoon and Dunn [14]. 
These workers also described cross-linking of e through 
the Cys at position 38 to the 3' subunit using p-azido- 
phenacyl bromide and N-[4-(p-azidosalicylamido)butyl]- 
3'-(2'-pyridyldithio)propionamide as cross-linkers, but these 
reagents gave very low yields of product, precluding activ- 
ity studies. 
Fig. 1 shows cross-linking of ECF~ isolated from the 
mutant eH38C with TFPAM-6, a recently developed cross 
linker [11], which has generated cross-linked products in 
high yields in our previous studies [11,24]. Fig. 1, part A 
shows the NaDodSO 4 polyacrylamide gel of samples 
cross-linked in both ADP + Mg 2+ and ATP + EDTA con- 
taining buffers, after staining with Coomassie brilliant 
blue; part B shows a Western blotting analysis of the 
sample reacted with TFPAM in ATP + EDTA. A cross- 
linked product between the y and E subunits was obtained 
under both nucleotide conditions that migrates under the /3 
subunit (resolved by antibody blotting). The yield of this 
cross-linked product in ADP + Mg, ATP + EDTA, and 
AMP.PNP + Mg (not shown) was similar and 20-30% 
based on the disappearance of the 3/ and • subunits from 
the gel profile. At these yields of cross-linked product, 
there was no significant effect on ATPase activity, i.e., 
21-25 p, mol ATP hydrolyzed per min per mg enzyme 
before photolysis compared with 21-23 p, mol ATP hydro- 
lyzed per min per mg enzyme after photolysis. In this 
respect, the data for the •H38C mutation are the same as 
with the •S10C mutation, where cross-linking of • to the 
3/ subunit had very little effect on ATPase activity [11]. In 
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Fig. 1. Cross-linking of ~H38C mutant Fj ATPase. (A) 540 /xg of ECF I 
in 100 ~zl of buffer (50 mM Mops (pH 7.5), 0.5 mM EDTA and 10% 
glycerol) was labeled with 200 tzM TFPAM-6 for 1 h at room tempera- 
ture. Excess label was removed by two consecutive passages through 
centrifuge columns in Sephadex G50 in the same buffer. 5 mM ATP 
(lanes 1 and 2) and 5 mM ATP+5.5 mM MgCI 2 (lanes 3 and 4), 
respectively were added to this buffer, and samples either kept in the dark 
(lanes 1 and 3) or photolyzed at 366 nm for 2 h at room temperature 
(lanes 2 and 4). 50/xg protein was applied on each lane and electrophore- 
sis carried out on a NaDodSO 4 containing 10-18% gradient polyacryl- 
amide gel, which was stained with Coomassie brilliant blue. (B) Im- 
munoblot of 30 /~g ECF I, which was cross-linked in the presence of 5 
mM ATP+0.5 mM EDTA (as lane 2 in (A)), using monoclonal ntibod- 
ies against the indicated subunits. 
contrast, the cross-linking of • to the ce subunit via a Cys 
at El08 inhibited activity [11]. 
3.2. Accessibilit3' o f  introduced Cys residues in the various 
• subunit mutants 
Previous studies have shown that the Cys introduced at 
positions 10, 38, and 108 of the • subunit is, in all cases, 
reactive to maleimides in isolated ECF I [11,14]. To exam- 
ine the reactivity of the Cys at these sites in intact ECFj F 0, 
this complex was purified from each of the mutants and 
the binding of [14C]NEM measured. The data are summa- 
rized in Table 1. [14C]NEM was readily incorporated into 
the Cys at positions 10 or 108. However, • subunit in 
ECF~F 0 from the mutant H38C was unreactive to 
[~4C]NEM, the small amount of radioactivity running at 
the position of the • subunit being about the same as that 
for enzyme preparations not containing a Cys in the • 
subunit (Table l). 
3.3. Reconstitution studies with ECF  1 f rom the • subunit 
mutants 
Shielding of the Cys at position 38 of the • subunit 
from modification in ECF~F 0, but not in isolated ECF~, 
suggests that this site is in the interface between the F~ and 
F 0 parts, a possibility that was examined further in recon- 
stitution experiments. ECF~ isolated from the three • sub- 
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Table 1 
[~4C]NEM incorporation i to ECFIF 0 isolated from the E subunit mu- 
tants 
NEM incorporation (mol lac per mol subunit) 
Mutant 3' subunit a S subunit b E subunit c
Control(3'S8C) d 0.78 0.62 0.08 
eS10C 0.07 0.72 0.80 
eH38C 0.11 0.87 0.10 
eSI08C 0.15 1.02 0.70 
There are two intrinsic Cys residues in the wild-type 7 subunit but these 
are unreactive as indicated by the incorporation of [14C]NEM into this 
subunit in the e subunit mutants. 
h There is one reactive intrinsic Cys residue in the S subunit. 
There are no intrinsic Cys residues in the wild-type e subunit and hence 
the small amount of labeling by [14C]NEM in the gel in the region of this 
subunit in the 3' subunit mutants represents background labeling. 
a yS8C is described in Aggeler and Capaldi [24]. 
unit mutants, with or without subsequent modification of 
the introduced Cys residue, was reacted with vesicles 
containing F0 (obtained as described in the Experimental 
procedures ection), and bound ECFj separated from free 
enzyme by two centrifugation steps. Reconstituted ECF 1F 0 
preparations were then examined for proton pumping ac- 
tivity, DCCD sensitivity and for LDAO-activated ATPase 
activity. Modification of the Cys at positions 10 (Fig. 2) or 
108 (result not shown) by NEM had no effect on proton 
translocation as measured by the fluorescence quenching 
of 9-amino-6-chloro-2-methoxyacridine (ACMA) (Fig. 2). 
There was no effect on DCCD sensitivity of modification 
of the Cys at positions 10 or 108 by any of several 
maleimides of different sizes and hydrophobicity. In both 
mutants, the DCCD inhibition of ATPase activity both 
before and after Cys modification was 56-64%, which is 
the same as for wild-type ECFIF 0 under identical condi- 
tions (Table 2). Finally, the LDAO-induced activation of 
the ATPase activity was unaltered by the various modifica- 
tions of Cys-10 or 108 (Table 3). LDAO disrupts the 
interaction between the F 1 and F 0 parts, relieving inhibi- 
tion of ATPase activity caused by this association [25]. 
Therefore, the difference in activity with and without 
LDAO present in the assay is a measure of the integrity of 
the F IF 0 interaction. 
In contrast to the results for Cys-10 and -108, modifica- 
tion of the Cys at position 38 drastically altered the FiF O 
interaction. As shown in Fig. 2, unmodified ECF l from 
this mutant showed good proton pumping function in the 
reconstitution system while, with NEM-modified enzyme, 
proton translocation was drastically impaired. Also, with 
maleimide modification of the Cys at position 38, DCCD 
inhibition was significantly altered (Table 2) as was LDAO 
activation of the ATPase activity. Thus after NEM modifi- 
cation, DCCD inhibition was only 30%, half of that ob- 
tained with the unmodified enzyme. The LDAO activation 
was 6.2 as opposed to 4.3 before treatment. Modification 
of the Cys at position 38 with more bulky maleimides 
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Fig. 2. ACMA quenching of fluorescence in EH38C membranes. Mem- 
branes of eH38C were stripped of ECF t with 50 mM Tris-HC1 (pH 8.0), 
1 mM EDTA and 1 M KSCN, washed twice with 5 mM Tes (pH 7.0), 0.5 
mM DTT, 0.5 mM EDTA, 40 mM 6-aminohexanoic a id and 15% 
glycerol, and twice with 50 mM Tris-HC1 (pH 7.5), 5 mM MgSQ, 1 mM 
DTE and 10% glycerol. To 1 mg of ECF I-depleted membranes in 0.25 ml 
of the same buffer with 5 mM ATP were added 150 /zg of ECF I and the 
mixture was incubated for 5 h at room temperature and 16 h at 4 ° C. To a 
membrane suspension at0.2 mg/ml in 10 mM Hepes (pH 7.5), 100 mM 
KCI, 5 mM MgC1 e were added 3.6/zM valinomycin (as a K + ionophore), 
followed by 1 tzM ACMA (quenchable fluorescent dye to follow pH 
changes), 0.5 mM NADH (electron transfer substrate), 2 mM KCN (to 
block the terminal oxidase of the respiratory chain), 2 mM ATP (as 
substrate) and 3.6 /xM nigericin (to dissipate the ion gradients) in that 
order. ECF I from ESIOC, unmodified (scan a) and NEM-modified (scan 
b); ECF I from ~H38C, unmodified (scan c) and NEM-modified (scan d); 
no ECF t added (scan e). 
Table 2 
DCCD inhibition of ECF IF 0 from the various E subunit mutants 
Modifying reagent e subunit mutant 
SIOC S108C H38C 
- 64 56 + 6(4)  64  + 7(8)  
NEM 60 n.d. 30(2) 
TFPAM-6 60 59(2) 28 4- 2(4) 
CM 51 n.d. 26(2) 
RM 59 55 25 
MBB 60 55(2) 28 + 7(3) 
Numbers in parentheses show the number of independent measurements. 
Others are the results of a single experiment in duplicate. ECF I (76 tzg) 
was added to ECF 0 (28 /xg) reconstituted in egg lecithin vesicles 
suspended in 0.5 ml 50 mM Tris-HCl (pH 7.5), 5 mM MgSO4, 5 mM 
ATP, 1 mM DTE and 10% glycerol, and the mixture incubated at room 
temperature for 8 h and then at 4 ° C for 16 h. After removal of free ECF I , 
DCCD inhibition was determined, n.d. = not determined. Values repre- 
sent the inhibition of ATP hydrolysis of ECF I F 0 by DCCD expressed as a 
percentage of this activity of the uninhibited enzyme. 
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resulted in somewhat smaller levels of  DCCD inhibition 
and higher LDAO activity, e.g., with CM, LDAO activa- 
tion was 8.3. These reconstitution studies, therefore, estab- 
lish that modif ication of the Cys at position 38 - but not 
that at positions 10 or 108 - of the • subunit affect the 
interaction between F L and F 0. 
3.4. Cross-linking studies with • mutants in ECF~ F o 
~ ~ ~=~i~ ¸¸~¸ ¸ - Oc-~ 
(I 
Cross-l inking studies with ECFj from the various mu- 
tants have provided information on near-neighbor interac- 
tions in the complex, and in the cases of  the mutants 
• S 10C and • 108C, showed nucleotide dependent confor- 
mation changes in the protein [11]. Similar cross-l inking 
studies were conducted using ECF1F o isolated from the 
three mutants. Fig. 3 shows the results for the mutant 
e SIOC. Two cross-l inked products were obtained on TF- 
PAM-6 modif ication and subsequent UV photolysis: one 
involving subunits c~ and 6, the second involving y and • 
subunits; both of  these products were obtained in experi- 
ments using isolated ECF~ [I 1]. As evident in Fig. 3, the 
yield of  cross-l inking from the Cys at position 10 of • to 
the y subunit was nucleotide-dependent, being signifi- 
cantly higher in Mg 2+ AMP.PNP or ATP + EDTA than in 
ADP + Mg 2+ (generated in catalytic sites by addition of 
ATP + Mg 2+ fol lowed by enzyme turnover). This is the 
same result obtained in isolated ECFj ,  and indicates that 
the interaction of  F l with F 0 does not hinder the nucleotide 
dependent conformational change around position 10 of 
the • subunit. The ce-6 subunit cross-l inked product was 
present in the different nucleotide conditions, as observed 
with isolated ECF~. Note that a /3-6 product seen in low 
yield in ECF~, was not observed in ECF IF 0 (in any of  the 
mutants studied). 
Studies with the mutant eS I08C using TFPAM-6  
showed cross linking of • to an ce subunit; the yield of  
which was lower in AMP • PNP + Mg than in ADP + Mg 
(result not shown) as reported already for isolated ECF]. 
Cross-l inking was obtained between the • and y subunits 
in ECF]F  0 from the mutant •H38C after first reacting the 
F 1 part with the maleimide group of TFPAM-6  (in the 
a 
• b 
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Fig. 3. Cross-linking of ECF u F 0 of" e S10C mutant. ECF t F 0 was reconsti- 
tuted in egg-lecithin vesicles at lipid:protein = 1 : 1 (w/w), by dialysis and 
collected by centrifugation at 4°C for 1 h at 45000 rpm in a Beckman 
Ti60 rotor. The vesicles were resuspended in 50 mM Mops (pH 7.0), 2 
mM MgCI 2, 20 /xM DTT and 10% glycerol. 400 /xg ATP-synthase at a 
concentration of 1 mg/ml was labeled with 200 /xM TFPAM-6. Excess 
of label was removed by centrifugation at 100000X g for 40 rain. The 
pellet was resuspended in 0.8 ml of the same buffer and split in half. One 
sample was supplemented with 2 mM ATP (lanes I and 2), the other with 
2 mM AMP-PNP (lanes 3 and 4). The ATP-synthase was then kept at 
room temperature under stirring for 3 h either in the dark (lanes ! and 4) 
or photolyzed (lanes 2 and 3). 150 /xl aliquots containing 70 /~g enzyme 
were applied on a 10-18% gradient polyacrylamide gel, which was 
stained with Coomassie brilliant blue. 
dark) and then rebinding to F 0 before photolysis (result not 
shown). There was no obvious nucleotide dependence of 
cross-l inking from the Cys at position 38 in ECF l or in the 
reconstituted ECF~ F o. 
Table 3 
LDAO activation of vesicles reconstituted with ECF t F 0 from the differ- 
ent E subunit mutants 
Modifying reagent e subunit mutant 
SIOC SI08C H38C 
- 3.6 4.3_+0.3(4)  4.3_+0.7(8) 
NEM 3.7 n.d. 6.2(2) 
TFPAM-6 3.9 4.8(2) 7.2 _+ 0.6(5) 
CM 3.8 n.d. 8.3 _+ 0.3(3) 
MBB 3.4 3.3(2) 6.0_+ 0.8(3) 
Numbers in parentheses are the number of independent measurements as 
in Table 2. n.d., not determined. Values are the ATPase activity of 
ECFIF o in the presence of LDAO divided by this activity in the absence 
of the detergent. 
4. D iscuss ion  
The arrangement of  the e subunit in the ECF nF 0 com- 
plex and the functions that this subunit plays remains to be 
fully elucidated. Unfortunately, in the recently-studied 
crystal form of the mitochondrial F 1 (MF~) [26], the 6 
subunit, which is the homologue of the e subunit of ECF 1, 
was disordered and no high-resolution structure of this 
subunit could be obtained. Sequence prediction algorithms 
suggest that the N-terminal two-thirds of  the e subunit is 
predominantly a /3-sheet structure, while the C-terminal 
third is arranged as an c~-helical structure. Our ongoing 
NMR determination of  the purif ied • subunit supports this 
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structural arrangement (Wilkens, S. and Capaldi, R.A., 
unpublished ata). Moreover, we find that a truncated form 
of the e subunit, containing residues 1-95, is mostly 
/3-sheet with no observable c~-helical structure. Such data 
indicate a two-domain structure of the • subunit, as first 
suggested by the functional studies of Jounouchi et al. [27] 
and Kuki et al. [28]. These workers have shown that a 
mutant in which the • subunit has been truncated to 
remove the C-terminal one third (residues 79-138 are 
missing) can still grow by oxidative phosphorylation. 
Evidence that the • subunit is a part of the stalk has 
been obtained by cryoelectron microscopy studies of ECF~ 
[9] as well as from low resolution X-ray structural studies 
of MF l (which show the 6 subunit of this complex is in a 
40 A extension) [29]. The results presented here are a clear 
indication that the • subunit must be in the stalk with the 
N-terminal domain around residue 38 in the interface with 
one of the F 0 subunits. Thus, a Cys at position 38 was 
found to be shielded from reaction with NEM in intact 
ECF~F 0, although this Cyso was reacted readily with 
maleimides as large as a 27 A gold-containing maleimide 
in ECF~ [9]. Modification of ECF~ from the mutant •H38C 
with NEM did not prevent the F 1 part from rebinding to 
F 0, but the interaction between the two parts was altered, 
as judged by a reduced DCCD sensitivity of the ATPase 
activity and an increased LDAO activation. Most impor- 
tantly, NEM modification of the Cys at position 38 uncou- 
pled ATP hydrolysis from proton pumping in the reconsti- 
tuted F 1F 0. 
Additional evidence of the close functional relationship 
between the N-terminal part of the • subunit and the F 0, 
specifically the c subunit, comes from studies reported 
recently by Zhang et al. [30]. These workers showed that 
an uncoupled mutant of the c subunit in which Gln-42 was 
converted to Glu is suppressed by a change of a Glu at 
position 31 of the • subunit to a Gly, Val or Lys. Such 
data are suggestive, but not conclusive evidence, of the 
interaction of the N-terminal domain with the F 0. Suppres- 
sor effects can occur at a distance as indicated by the 
recent studies of Futai and colleagues on the /3 and y 
subunits [31-33]. For example, these workers have shown 
that the mutation of Gly-149 to a Cys inhibits the ATPase 
activity of ECFj, but that this deleterious mutation is 
suppressed by a change of Ser-174 to a Phe, Val-198 to an 
Ala, or Glu-192 to a Val, all residues significantly distant 
from Gly149 [31]. 
It is important o note that the region of the • subunit 
around His-38 (Val-20-Ala-44) is the only region that has 
strong homology with the • subunit of chloroplasts and the 
8 subunit of mitochondrial Fj. LaRoe and Vik [34] have 
shown that some mutations at positions 31 and 38 affect 
the coupling of ATP hydrolysis with proton pumping. 
As reported by Aggeler et al. [11] for ECF 1, and as 
shown here for ECF IF o, the e subunit can be cross-linked 
to an c~ subunit via Cys-108 using the TFPAM series of 
cross-linkers. The e subunit can also be cross-linked to a 
/3 subunit in ECF~ and in ECFIF o by EDC [12,23,35]. 
Dunn and colleagues have shown that this zero length 
crosslink generated in high yield by EDC is between the 
so-called DELSEED region of the /3 subunit (residues 
380-386) and a region of • close to Ser-108 [13]. We 
have now confirmed the close proximity of the • subunit 
at Ser-108 to the DELSEED region, by disulfide bond 
formation in the double mutant /3E381C;•S108C (Ag- 
geler, R. and Capaldi, R.A., unpublished ata). 
An important and not yet fully answered question is: 
what is the role of the C-terminal part of the • subunit? As 
described already, the mutational studies of Kuki et al. [28] 
indicate that the C-terminal 60 residues are dispensable for 
oxidative phosphorylation by ECF~F 0. One suggestion is 
that the • subunit is an inhibitor of free ECFj in the cell, 
thereby preventing depletion of ATP during F t F 0 assembly 
[36]. Removal of the • subunit causes as much as a 
10-fold increase in the rate of ATP hydrolysis of isolated 
ECF 1, and this inhibitory function has been localized to the 
C-terminal part of the • subunit by proteinase digestion 
[35] and to the region 80-93 in mutagenesis experiments 
[28]. Cleavage of the C-terminal region of the • subunit in 
ECF~F 0 increases ATPase activity without affecting ATP- 
driven proton translocation [23]. 
We have previously found that ECF~ from the mutant 
eS10C has a much higher basal activity than the wild-type 
enzyme, i.e., 3-fold higher [11]. It is shown here that 
ECF 1F 0 for this mutant also has a higher activity than the 
wild-type, in this case a 2-fold activation, supporting a role 
of the • subunit as at least a partial inhibitor of the 
ATPase activity in ECFIF 0. 
Based on cross-linking data in ECF I [11], and now in 
ECF~F0, the Cys at position 10 of the • is in close 
proximity to the y subunit. Moreover, there is a nucleotide 
dependence of the yield of the y-E crosslink product in 
both preparations. There is also cross-linking between the 
Cys at position 38 of e and the y subunit. This is 
significant because, with the data presented here, it places 
the y subunit close to subunits of F 0. We are now studying 
mutants containing cysteines introduced in the polar loop 
of subunit c, and have been able to obtain cross-links from 
c to the 3/ subunit (Watts, S. and Capaldi, R.A., unpub- 
lished results). If the 3' subunit contacts the proton channel 
containing c subunits (and possibly the a subunit), trans- 
mission of conformational changes between catalytic sites 
and the proton channel could be entirely within the 
subunit, with the • subunit acting only as a regulator of 
conformational coupling. More studies are needed to dis- 
tinguish whether the • subunit acts directly in the coupling 
process or indirectly in this postulated regulatory role. 
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